LifeMD to Present at the H.C. Wainwright Annual Global Investment Conference

Rhea-AI Summary

LifeMD, a fast-growing telehealth company, announced its participation in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021. The event will feature virtual presentations and one-on-one investor meetings. LifeMD specializes in providing cash pay virtual medical treatments, prescription medications, and over-the-counter products to patients nationwide. The company's platform allows easy access to licensed medical professionals, enhancing patient convenience.

NEW YORK, Sept. 08, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescription medications and over the counter products to patients across all 50 states today announced that management will present virtually at the H.C. Wainwright 23^rd Annual Global Investment Conference on September 13^th, 2021 and be available for virtual 1x1 investor meetings. To request a meeting with management, please contact meetings@hcwco.com.

About LifeMD
LifeMD, Inc. is a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescription medications and over the counter products to patients across all 50 states. LifeMD's telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate, prescription medications and over-the-counter products delivered directly to the patient's home.  To learn more, go to LifeMD.com. 

Cautionary Note Regarding Forward Looking Statements
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.

Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.

Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.

Company Contact                                
LifeMD, Inc.        
Marc Benathen, CFO
marc@lifemd.com

Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
arr@lifesciadvisors.com 

FAQ

What is LifeMD's stock symbol and when will they present at the H.C. Wainwright Conference?

LifeMD's stock symbol is LFMD, and they will present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021.

What services does LifeMD offer to patients?

LifeMD offers cash pay virtual medical treatments, prescription medications, and over-the-counter products delivered to patients across all 50 states.

How can investors request a meeting with LifeMD's management?

Investors can request a one-on-one meeting with LifeMD's management by contacting meetings@hcwco.com.

What is LifeMD's focus in the telehealth market?

LifeMD focuses on providing affordable and convenient telehealth services, enabling virtual access to medical care from licensed providers.

What does LifeMD's telemedicine platform provide?

LifeMD's telemedicine platform allows patients to receive virtual consultations with licensed healthcare providers and access prescription medications.